Director/PDMR Shareholding
On October 14, 2025, Natalie Walter, Group General Counsel and Company Secretary of Oxford Biomedica PLC, exercised 28,321 LTIP options and 39,679 DBP options at a nil exercise price. Subsequently, on October 15, 2025, she disposed of 68,000 ordinary shares at an average price of £6.116876 per share, resulting in a total value of £415,947.568. These transactions took place on the London Stock Exchange, Main Market (XLON).
Select text to share a quote on X · sign in to keep highlights & notes in your OXB notes
Oxford, UK - 16 October 2025: OXB (LSE: OXB) (the "Company"), a global quality and innovation-led cell and gene therapy CDMO, today announces that Natalie Walter, Group General Counsel and Company Secretary of the Company exercised 28,321 LTIP options and 39,679 DBP options at nil exercise price on 14 October 2025 and disposed of 68,000 shares at an average price of £6.116876 per share on 15 October 2025.
| a) | Name | Natalie Walter | ||||
| 2. | Reason for the notification | |||||
| a) | Position/status | Person Discharging Managerial Responsibility | ||||
| b) | Initial notification/ amendment | Initial Notification | ||||
| 3. | Details of the Issuer | |||||
| a) | Full name of the entity | Oxford Biomedica plc | ||||
| b) | LEI code | 213800S1GVQNXQ15K851 | ||||
| a) | Date of the transaction | 2025-10-14 | ||||
| b) | Description of the financial instrument | Ordinary Shares of 50 pence each | ||||
| c) | Identification code | ISIN: GB00BDFBVT43 | ||||
| d) | Nature of the transaction | Exercise of LTIP Options at nil exercise price | ||||
| e) | Place of the transaction | London Stock Exchange, Main Market (XLON) | ||||
| f) | Currency | GBP - British pound | ||||
| g) | Price(s) and volumes(s) |
| ||||
| h) | Aggregated information - Aggregate volume - Price - Aggregated total | 28,321 £0.00 £0.00 | ||||
| a) | Name | Natalie Walter | ||||
| 2. | Reason for the notification | |||||
| a) | Position/status | Person Discharging Managerial Responsibility | ||||
| b) | Initial notification/ amendment | Initial Notification | ||||
| 3. | Details of the Issuer | |||||
| a) | Full name of the entity | Oxford Biomedica plc | ||||
| b) | LEI code | 213800S1GVQNXQ15K851 | ||||
| a) | Date of the transaction | 2025-10-14 | ||||
| b) | Description of the financial instrument | Ordinary Shares of 50 pence each | ||||
| c) | Identification code | ISIN: GB00BDFBVT43 | ||||
| d) | Nature of the transaction | Exercise of DBP Options at nil exercise price | ||||
| e) | Place of the transaction | London Stock Exchange, Main Market (XLON) | ||||
| f) | Currency | GBP - British pound | ||||
| g) | Price(s) and volumes(s) |
| ||||
| h) | Aggregated information - Aggregate volume - Price - Aggregated total | 39,679 £0.00 £0.00 | ||||
| a) | Name | Natalie Walter | ||||
| 2. | Reason for the notification | |||||
| a) | Position/status | Person Discharging Managerial Responsibility | ||||
| b) | Initial notification/ amendment | Initial Notification | ||||
| 3. | Details of the Issuer | |||||
| a) | Name | Oxford Biomedica plc | ||||
| b) | LEI code | 213800S1GVQNXQ15K851 | ||||
| a) | Date of the transaction | 2025-10-15 | ||||
| b ) | Description of the financial instrument | Ordinary Shares of 50 pence each | ||||
| c) | Identification code | ISIN: GB00BDFBVT43 | ||||
| d) | Nature of transaction | Sale of shares | ||||
| e) | Place of the transaction | London Stock Exchange, Main Market (XLON) | ||||
| f) | Currency | GBP - British pound | ||||
| g) | Price(s) and volumes(s) |
| ||||
| h) | Aggregated information - Aggregate volume - Price - Aggregated total | 68,000 £6.116876 £415,947.568 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.